December 23

Measles, Mumps, Rubella (MMR) Vaccine “Safe and Effective”?

The inconvenient evidence that won’t go away…

According to the Centers for Disease Control (CDC):

  • During the 10-year period, 2004 -2015, there were ZERO deaths due to measles.
  • During the same period, the government surveillance system –Vaccine Adverse Effect Reporting System (VAERS) — 108 babies died following MMR vaccination.

The following information was compiled and first reported by the National Vaccine Information Center, a respected national grass roots organization formed in 1982, by parents whose children have been injured by a vaccine.  The Washington Post saw fit to denigrate the organization for accepting financial support from Joseph Mercola, an osteopathic physician who is a successful merchant of vitamin C and D supplements and alternative health products.

The Washington Post reporters who authored the December 19th hatchet job – Neena Satija, Lena H. Sun, with contributions by Mark Guarino, Alice Crites and Everdeen Mason – adhered to the hackneyed 20-year old repeated refrain that lays the blame for the controversy ignited by the MMR vaccine on one doctor. The controversy has escalated in response to the accumulating empirical evidence of children who have suffered irreversible harm, which vaccine stakeholders dismiss as “anecdotal”; coupled with increasingly aggressive government-mandated vaccination policies, and a vastly inflated childhood vaccination schedule.

The mainstream media is no longer independent or impartial; their reporting is slanted inasmuch as their owners and advertisers are stakeholders in the multi-billion dollar business of vaccines. The media would have us all believe that Dr. Andrew Wakefield is to blame for having single-handedly undermined public trust in patently false official claims and assurances that “vaccines are safe and effective”. We are supposed to believe that Dr. Wakefield made up none-existing safety problems related to the MMR and problems regarding vaccines generally.

Here are some sobering facts that the the financially vested stakeholders in vaccines don’t want you to know: 

1) In 1998, the same year that the controversial “Wakefield Lancet study” was published, a review was published in the journal Pediatrics. The authors were public health officials and attorneys with the U.S. Vaccine Injury Compensation Program who reviewed the medical records of 48 children aged 10 to 49 months who were vaccinated with the MMR between 1970 and 1993. They reported that:

“The onset of neurologic signs or symptoms occurred with a nonrandom, statistically significant distribution of cases on days 8 and 9. No cases were identified after the administration of monovalent mumps or rubella vaccine. This clustering suggests that a causal relationship between measles vaccine and encephalopathy may exist as a rare complication of measles vaccination.”

2) Twenty years later, the latest version is the MMRV vaccine which added the Varicella virus (chicken pox) to the MMR vaccine.  The Centers for Disease Control (CDC) acknowledged (February 2018, here and here) that rare serious side effects, of both MMR and MMRV include:
brain damage, coma, chronic seizure disorder, lowered level of consciousness and loss of hearing.

3) In April 2019, the Informed Consent Action Network (ICAN), a non-profit which investigates the safety of medical procedures, pharmaceutical drugs and vaccines, and educating the public about their right to informed consent to all medical procedures, received documentation from the Food and Drug Administration (FDA) in response to their Freedom of Information Act (FOIA) request for documents pertaining to the clinical studies submitted for the MMRII vaccine approval.

The licensure documents revealed that only 8 pre-licensing clinical trials were completed prior to FDA approval of MMRII vaccine licensing. These trials involved a total of 834 children who were followed for only 42 days. Of these 8 studies, 3 studies involved less than 350 children compared the MMRII vaccine to another vaccine. And the remaining 5 studies compared health outcomes of children vaccinated with different lots of the MMRII vaccine. These trials do not meet legitimate scientific standards requiring placebo-controlled trials.  The documents reveal that a shocking number of children in all 8 pre-clinical licensing studies, suffered high rates of upper respiratory illness (55%) and gastrointestinal illness (40%) were reported, along with additional side effects which included fever, malaise, and measles-like rash.

4)As of May 31, 2019, there have been more than 94,972 reports of measles vaccine reactions, hospitalizations, injuries and deaths following measles vaccinations made to the federal Vaccine Adverse Events Reporting System (VAERS), including 468 related deaths, 7,127 hospitalizations, and 1,820 related disabilities. However, the numbers of vaccine-related injuries and deaths reported to VAERS may not reflect the true number of serious health problems that occur after MMR vaccination.”

5) As of July 1, 2019 there have been 1,274 claims filed in the federal Vaccine Injury Compensation Program (VICP) for 82 deaths and 1,192 injuries that occurred after measles vaccination. Of that number, the U.S. Court of Claims administering the VICP has compensated 484 children and adults, who have filed claims for measles vaccine injury.

6) Product Information Insert for PROQUAD (MMRV), the latest version of the MMR was filed by Merck in January 2019. The product insert reported the following documented serious adverse effects following vaccination:

  • measles;
  • atypical measles;
  • vaccine strain varicella;
  • varicella-like rash;
  • herpes zoster;
  • herpes simplex;
  • pneumonia & respiratory infection;
  • pneumonitis;
  • bronchitis;
  • epididymitis;
  • cellulitis;
  • skin infection;
  • subacute sclerosing panencephalitis;
  • aseptic meningitis;
  • thrombocytopenia;
  • aplastic anemia
    (anemia due to the bone marrow’s inability to produce platelets, red and white blood cells);
  • lymphadenitis (inflammation of the lymph nodes);
  • anaphylaxis including related symptoms of peripheral, angioneurotic and facial edema;
  • agitation;
  • ocular palsies;
  • necrotizing retinitis (inflammation of the eye);
  • nerve deafness;
  • optic and retrobulbar neuritis (inflammation of the optic nerve);
  • Bell’s palsy (sudden but temporary weakness of one half of the face);
  • cerebrovascular accident (stroke);
  • acute disseminated encephalomyelitis;
  • measles inclusion body encephalitis;
  • transverse myelitis;
  • encephalopathy;
  • Guillain-Barre Syndrome;
  • syncope (fainting);
  • tremor;
  • dizziness;
  • paraesthesia;
  • febrile seizure;
  • afebrile seizures or convulsions;
  • polyneuropathy
    (dysfunction of numerous peripheral nerves of the body);
  • Stevens-Johnson syndrome;
  • Henoch-Schönlein purpura;
  • acute hemorrhagic edema of infancy;
  • erythema multiforme;
  • panniculitis;
  • arthritis;
  • death

Five years earlier, a Canadian study published in 2014, reported that the risk of febrile seizures was double in children receiving the MMR-V vaccine compared to infants who received separate doses of MMR and varicella vaccines. And a 2015 meta-analysis published in the journal Vaccine reported a two-fold increase in febrile seizures between 5 and 12 days or 7 and 10 days following MMR-V vaccination in children between the ages of 10 and 24 months.

7) The Product Information Insert for the MMRII, filed by Merck in May 2017, reported the following serious adverse complications:

  • brain inflammation (encephalitis)
  • encephalopathy (chronic brain dysfunction);
  • panniculitis
    (inflammation of the fat layer under the skin); \atypical measles;
  • syncope (sudden loss of consciousness, fainting);
  • vasculitis (inflammation of the blood vessels);
  • pancreatitis (inflammation of the pancreas);
  • diabetes mellitus;
  • thrombocytopenia  purpura (blood disorder);
  • Henoch-Schönlein purpura
    (inflammation and bleeding in the small blood vessels);
  • acute hemorrhagic edema of infancy
    (rare vasculitis of the skin’s small vessels occurring in infants);
  • leukocytosis (high white blood cell count);
  • anaphylaxis (shock);
  • bronchial spasms;
  • pneumonia;
  • pneumonitis(inflammation of the lung tissues);
  • arthritis and arthralgia (joint pain);
  • myalgia (muscle pain);
  • polyneuritis (inflammation of several nerves simultaneously);
  • measles inclusion body encephalitis
    (disease affecting the brain of immunocompromised persons);
  • subacute sclerosing panencephalitis
    (fatal progressive brain disorder thought to be caused by exposure to the measles virus);
  • Guillain-Barre Syndrome;
    (disease where the body’s immune system attacks the nerves);
  • acute disseminated encephalomyelitis
    (ADEM- brief widespread inflammation of the nerve’s protective covering);
  • transverse myelitis
    (inflammation of the spinal cord);
  • aseptic meningitis;
  • erythema multiforme
    (skin disorder from an allergic reaction or infection);
  • urticarial rash
    (hives, itching from an allergic reaction);
  • measles-like rash;
  • Stevens-Johnson syndrome
    (severe reaction causing the skin and mucous membranes to blister, die, and shed);
  • nerve deafness
    (hearing loss from damage to the inner ear);
  • otitis media (ear infection);
  • retinitis (inflammation of the retina of the eye);
  • optic neuritis (inflammation of the optic nerve);
  • conjunctivitis (pink eye);
  • ocular palsies (dysfunction of the ocular nerve);
  • epididymitis (inflammation of the epididymis);
  • paresthesia (burning or prickling of the skin);
  • death.


Subscribe To Our Newsletter!

Sign up and be the first to find out the latest news and articles about what's going on in the medical field.

You may also like

November 21, 2023

Vera Sharav is joining Christine Anderson as special guest for the Make It Your Business event in

Read More
Vera Sharav Joins Christine Anderson for Make It Your Business – Dec 4, 2023 in New Jersey

November 21, 2023

Vera Sharav is premiering the movie Never Again is Now Global in New York City, December 1.

Read More
Never Again is Now Global – Premiere Screening – Dec 1, 2023 in New York City